Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3)

Clinical trial NCT05425732 · COMPLETED

Trial details

NCT number: NCT05425732
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Infection

Start date: 2022-07-13
Primary completion: 2023-05-18
Enrollment: 2663

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.